Kotra Industries Bhd (XKLS:0002) Margin of Safety % (DCF Dividends Based): N/A (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0002 Kotra Industries Bhd XKLS:0002
67 GF Score
Price RM3.80
GF Value RM4.33
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Kotra Industries Bhd Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Kotra Industries Bhd's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

XKLS:0002 vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kotra Industries Bhd Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Kotra Industries Bhd's Margin of Safety % (DCF Dividends Based) falls into.


XKLS:0002
67GF Score
Kotra Industries Bhd XKLS:0002
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?

Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued. The current stock price of RM3.80 is trading 12.2% below its estimated GF Value™ of RM4.33. GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0002:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: RM4.33 vs. price of RM3.80 (12.2% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kotra Industries Bhd Business Description

Address Jalan TTC 12, No. 1, 2 & 3, Cheng Industrial Estate, Melaka, MYS, 75250
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
67GF Score

Get the complete analysis for XKLS:0002

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.80
Price
RM4.33
GF Value